Depressive symptoms in older people with metabolic syndrome: Is there a relationship with inflammation?

International Journal of Geriatric Psychiatry

Volumn 28, Issue 3, 2013, Pages 242-247

  Viscogliosi, Giovanni ^a   Andreozzi, Paola ^a   Chiriac, Iulia Maria ^a   Cipriani, Elisa ^a   Servello, Adriana ^a   Marigliano, Benedetta ^a   Ettorre, Evaristo ^a   Marigliano, Vincenzo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

depression; low grade chronic inflammation; metabolic syndrome; older

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HIGH SENSITIVITY C REACTIVE PROTEIN; UNCLASSIFIED DRUG;

AGE; AGED; ARTICLE; BODY MASS; COGNITION; DEPRESSION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GERIATRIC DEPRESSION SCALE; GLUCOSE BLOOD LEVEL; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MINI MENTAL STATE EXAMINATION;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; COGNITION; DEPRESSIVE DISORDER; FEMALE; HUMANS; INFLAMMATION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES;

EID: 84873570493     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.3817     Document Type: Article

References (22)

1. Bertoni AG, Burke GL, Owosu JA, et al. 2010. Inflammation and the incidence of type 2 diabetes: the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care 33: 804810.
2. Bremmer MA, Beekman AT, Deeg DJ, et al. 2008. Inflammatory markers in late-life depression: results from a population-based study. J Affect Disord 106: 249255.
3. Cao JJ, Arnold AM, Manolio TA, et al. 2007. Association of carotid artery intimamedia thickness, plaques, and C-reactive protein with future cardiovascular disease and all-cause mortality: the Cardiovascular Health Study. Circulation 116: 3238.
4. Cohen HJ, Pieper CF, Harris T, Rao KM, Currie MS. 1997. The association of plasma IL-6 levels with functional disability in community-dwelling elderly. J Gerontol A Biol Sci Med Sci 52: 201208.
5. Danner M, Kasl SV, Abramson JL, Vaccarino V. 2003. Association between depression and elevated C-reactive protein. Psychosom Med 65: 347356.
6. Dunbar JA, Reddy P, Davis-Lameloise N, et al. 2008. Depression: an important comorbidity with metabolic syndrome in a general population. Diabetes Care 31: 236873.
7. Ershler WB, Keller ET. 2000. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu Rev Med 51: 245270.
8. Ford DE, Erlinger TP. 2004. Depression and C-reactive protein in US adults: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 164: 10101014.
9. (NCEP). 2001. Executive summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285: 248697.
10. Khuwaja AK, Lalani S, Dhanani R, et al. 2010. Anxiety and depression among outpatients with type 2 diabetes: a multi-centre study of prevalence and associated factors. Diabetol Metab Syndr 2: 72.
11. Lebowitz BD, Pearson JL, Schneider LS, et al. 1997. Diagnosis and treatment of depression in late life. Consensus statement update. JAMA 278: 118690.
12. Marette A. 2002. Mediators of cytokine-induced insulin resistance in obesity and other inflammatory settings. Curr Opin Clin NutrMetab Care 5: 377383.
13. Miller AH, Maletic V, Raison CL. 2009. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 65: 73241.
14. Moussavi S, Chatterji S, Verdes E, et al. 2007. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 370: 8518.
15. Newson RS, Hek K, Luijendijk HJ, et al. 2010. Atherosclerosis and incident depression in late life. Arch Gen Psychiatry 67: 114451.
16. Pan W, Stone KP, Hsuchou H, et al. 2011. Cytokine signaling modulates bloodbrain barrier function. Curr Pharm Des 17: 372940.
17. Rogowski O, Shapira I, Bassat OK, et al. 2010. Waist circumference as the predominant contributor to the micro-inflammatory response in the metabolic syndrome: a cross sectional study. J Inflamm 7: 35.
18. Skilton MR, Moulin P, Terra JL, Bonnet F. 2007. Associations between anxiety, depression, and the metabolic syndrome. Biol Psychiatry 62: 12517.
19. Soremekun M, Stewart R, Portet F, et al. 2010. Neurological signs and late-life depressive symptoms in a community population: the ESPRIT study. Int J Geriatr Psychiatry 25: 6728.
20. Tiemeier H, van Dijck W, Hofman A, et al. 2004. Relationship between atherosclerosis and late-life depression: the Rotterdam Study. Arch Gen Psychiatry 61: 369376.
21. Viscogliosi G, Andreozzi P, Chiriac IM, et al. 2011. Vascular depression in the elderly. Does inflammation play a role? Recenti Prog Med 102: 2616.
22. Yaffe K, Kanaya A, Lindquist K, et al. 2004: The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 292: 22372242.